Loading compound...
Small molecule research compound
GSK-461364 is a small molecule drug currently being studied in early-stage research (Phase 1) for the treatment of non-Hodgkin lymphoma.
How it worksThis drug is being researched for its ability to target specific biological processes related to non-Hodgkin lymphoma.
Used for
non-Hodgkin lymphoma
Conditions
non-Hodgkin lymphoma
Class
Small moleculeSmall molecule research compound
How to take
This compound is currently in the experimental phase (Phase 1) and is not yet approved for general use.
Talk to your doctor
Questions to ask
- ·Is GSK-461364 part of any clinical trials for lymphoma?
- ·What are the current research findings for GSK-461364?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.